Livzon Pharmaceutical Group Inc. (SHE:000513)
34.82
-0.51 (-1.44%)
At close: Feb 13, 2026
-2.95% (1Y)
| Market Cap | 28.22B -1.8% |
| Revenue (ttm) | 11.85B -0.1% |
| Net Income | 2.14B +5.8% |
| EPS | 2.38 +8.9% |
| Shares Out | 887.91M |
| PE Ratio | 14.60 |
| Forward PE | 16.50 |
| Dividend | 1.10 (3.16%) |
| Ex-Dividend Date | Jun 13, 2025 |
| Volume | 4,212,550 |
| Average Volume | 5,988,856 |
| Open | 35.28 |
| Previous Close | 35.33 |
| Day's Range | 34.82 - 35.42 |
| 52-Week Range | 32.94 - 44.87 |
| Beta | 0.37 |
| RSI | 40.33 |
| Earnings Date | Mar 25, 2026 |